Results 251 to 260 of about 3,735,339 (297)
Acinetobacter Baumannii Nosocomial Infections
Polish Journal of Surgery, 2013 Nosocomial infections caused by strains Acinetobacter baumannii strands are a growing clinical problem. The occurrence of multidrug-resistant strands is observed and that limits the ways of therapy considerably. The aim of the study was to determine the rate of infection and susceptibility spectrum of the species Acinetobacter baumannii isolated from ...
Karol, Sieniawski +4 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Treatment of Acinetobacter spp. infections
Expert Opinion on Pharmacotherapy, 2003Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of their important features is antimicrobial resistance that includes beta-lactams, aminoglycosides and quinolones. Imipenem, considered the most effective drug against Acinetobacter spp., is not universally active against clinical isolates and therapeutic options are ...
Anna S Levin
exaly +3 more sources
Intravenous Minocycline: A Review in Acinetobacter Infections
Drugs, 2016Intravenous minocycline (Minocin®) is approved in the USA for use in patients with infections due to susceptible strains of Gram-positive and Gram-negative pathogens, including infections due to Acinetobacter spp. Minocycline is a synthetic tetracycline derivative that was originally introduced in the 1960s. A new intravenous formulation of minocycline
Sarah L. Greig, Lesley J. Scott
openaire +3 more sources
Acinetobacter Infection in the ICU
Critical Care Clinics, 2008Acinetobacter is a formidable challenge to managing critically ill patients. This pathogen's ability to rapidly develop antimicrobial resistance to all currently available antimicrobial agents is concerning because increasing data support attributable mortality to these bacteria when associated with hospitalized patients with comorbidities and severe ...
Clinton K, Murray, Duane R, Hospenthal
openaire +2 more sources
Systematic Review of Invasive Acinetobacter Infections in Children [PDF]
Canadian Journal of Infectious Diseases and Medical Microbiology, 2010 INTRODUCTION: Clinicians are generally familiar with Acinetobacter as an etiological agent for serious nosocomial infections in intensive care units.
Jia Hu +2 more
exaly +2 more sources
Therapeutic options forAcinetobacter baumanniiinfections: an update
Expert Opinion on Pharmacotherapy, 2012 Introduction: Although the clinical importance of Acinetobacter pittii and Acinetobacter nosocomialis has increased in the nosocomial setting in the last decade, infections caused by Acinetobacter baumannii still have the highest clinical relevance.
Jordi Vila, Jeronimo Pachón
exaly +2 more sources
Infection with Acinetobacter in a burns unit
Burns, 1983In recent months 17 patients on the Burns Unit at St Lawrence Hospital have been infected with Acinetobacter anitratus. We present 4 patients who have been extremely ill and in whom Acinetobacter was considered to have played a prominent role. We stress the importance of opportunistic infection in burns patients and antibiotic resistance in this ...
A R, Green, M A, Milling
openaire +2 more sources
Treatment of Acinetobacter baumannii severe infections
Medicina Intensiva (English Edition), 2022Acinetobacter baumannii is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial infections, especially in intensive care units (ICUs) and immunocompromised patients. A. baumannii has developed a broad spectrum of antimicrobial resistance, associated with a higher mortality rate among infected patients compared with other non ...
R, Reina +2 more
openaire +2 more sources
Treatment approaches for carbapenem-resistant Acinetobacter baumannii infections
DrugsCarbapenem-resistant Acinetobacter baumannii has been associated with over three hundred thousand annual deaths globally. It is resistant to most available antibiotics and associated with high morbidity and mortality. No global consensus currently exists
Alina Iovleva, Vance G. Fowler, Y. Doi
semanticscholar +1 more source
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Microbial Pathogenesis, 2020BACKGROUND With the increasing rate of antibiotic resistance in Acinetobacter, the World Health Organization introduced the carbapenem-resistant isolates in the priority pathogens list for which innovative new treatments are urgently needed ...
Alireza Neshani +5 more
semanticscholar +1 more source